(Q30352400)

15 October 2017

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. (English)

1 reference

15 October 2017

0 references

Jonathan Cogen

1

1 reference

15 October 2017

Julia Emerson

2

1 reference

15 October 2017

Don B Sanders

3

1 reference

15 October 2017

Clement Ren

4

1 reference

15 October 2017

Michael S Schechter

5

1 reference

15 October 2017

Ronald L Gibson

6

1 reference

15 October 2017

Wayne Morgan

7

1 reference

15 October 2017

Margaret Rosenfeld

8

1 reference

15 October 2017

EPIC Study Group

9

1 reference

15 October 2017

9 June 2015

1 reference

15 October 2017

Pediatric Pulmonology

1 reference

15 October 2017

50

1 reference

15 October 2017

8

1 reference

15 October 2017

763-770

1 reference

Risk factors for the progression of cystic fibrosis lung disease throughout childhood

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Lung function decline from adolescence to young adulthood in cystic fibrosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

The role of female hormones on lung function in chronic lung diseases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Influenza-associated cystic fibrosis pulmonary exacerbations.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Cystic fibrosis and estrogens: a perfect storm

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Spirometric reference values from a sample of the general U.S. population

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Effect of high-dose ibuprofen in patients with cystic fibrosis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5462119

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

3 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Increased rate of lung function decline in Australian adolescents with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Pulmonary function growth velocity in children 6 to 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Infection, inflammation, and lung function decline in infants with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.23217

Better Nutritional Status in Early Childhood Is Associated with Improved Clinical Outcomes and Survival in Patients with Cystic Fibrosis

21 January 2018

1 reference

12 December 2020

Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort

1 reference

12 December 2020

Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients

1 reference

12 December 2020

Predictors of deterioration of lung function in cystic fibrosis

1 reference

12 December 2020

Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use

1 reference

12 December 2020

Identifiers

DOI

10.1002/PPUL.23217

1 reference

15 October 2017

1 reference

15 October 2017

1 reference